SynthesisFrontiers in neuroscience2025
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights.
Synthesis in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The ferroptosis-mediated domino effect: metabolic crosstalk from intervertebral disc degeneration to spinal deformity and cord injury: a mini review.Frontiers in neuroscience · 2026Review
- Exosome-derived ncRNAs and proteins: inflammation regulatory mechanisms and biomarker potential in spinal cord injury.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spinal cord injury (SCI) often leads to severe motor and sensory impairments, and current treatment methods have not achieved complete neural repair. In recent years, exosomes have become a research focus in the treatment of nerve injuries due to their important roles in intercellular information transfer, immune regulation, and neural repair. Our study conducts a scientometric analysis to map the research landscape related to exosomes in SCI. Methods: Articles and reviews related to exosome in SCI were retrieved from the Web of Science Core Collection and Scopus. Analysis was conducted using Microsoft Excel 2021, CiteSpace (6.4.R1), VOSviewer (1.6.18), the R software (4.4.3) bibliometrix package, etc. Results: Since 2018, the number of publications has rapidly increased. Fan Jin is the most academically influential author in the field, while Cai Weihua's research has received widespread recognition from researchers. China is the leading contributor among the 32 countries/regions. Among the 708 institutions, Central South University and Zhejiang University are the primary supporters. Conclusion: Our study show that the growing global interest in exosome-based therapies for SCI, marking an important step in understanding their preclinical potential. These therapies show promise in promoting neuroprotection, axonal regeneration, and modulating inflammation. Moving forward, future research will focus on further exploring the integration of exosome therapies with advanced drug delivery systems and regenerative medicine, aiming to enhance SCI treatments and tailor recovery strategies in preclinical models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.